AR027133A1 - Derivados de heteroarilo, su preparacion y uso. - Google Patents

Derivados de heteroarilo, su preparacion y uso.

Info

Publication number
AR027133A1
AR027133A1 ARP000106988A ARP000106988A AR027133A1 AR 027133 A1 AR027133 A1 AR 027133A1 AR P000106988 A ARP000106988 A AR P000106988A AR P000106988 A ARP000106988 A AR P000106988A AR 027133 A1 AR027133 A1 AR 027133A1
Authority
AR
Argentina
Prior art keywords
cr6r7
disorders
disorder
heteroarilo
derivatives
Prior art date
Application number
ARP000106988A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR027133A1 publication Critical patent/AR027133A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

Un derivado heteroarilo que tiene la formula 1 cualquiera de sus enantiomeros o caulquier mezcla de los mismos, o una sal de adicion de ácido del mismo,donde X es -O-, -S- o -CR4R5- y Y es -CR6R7-, -CR6R7-CR8R9- o -CR6=R7- o bien X e Y juntos forman un grupo -CR4=CR5- o -CR4-CR6R7-, Z es -O- o -S-; W es N, C oCH, n es 2, 3, 4, 5, 6, 7, 8, 9 o 10; m es 2 o 3; A es O o S, donde las líneas de puntos significan un enlace optativo, y R1, R2, R3, R4, R5, R6, R7, R8 y R9son tal como figuran en la memor ia. Los compuestos son considerados utiles para el tratamiento de trastornos afectivos tales como el trastorno de ansiedadgeneralizada, trastorno de pánico, trastorno obsesivo compulsivo, depresion, fobia social y trastornos de la alimentacion, así c omo trastornos neurologicostales como la psicosis.
ARP000106988A 1999-12-30 2000-12-28 Derivados de heteroarilo, su preparacion y uso. AR027133A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199901884 1999-12-30

Publications (1)

Publication Number Publication Date
AR027133A1 true AR027133A1 (es) 2003-03-12

Family

ID=8108797

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106988A AR027133A1 (es) 1999-12-30 2000-12-28 Derivados de heteroarilo, su preparacion y uso.

Country Status (22)

Country Link
US (1) US20030050306A1 (es)
EP (1) EP1246820A1 (es)
JP (1) JP2003519229A (es)
KR (1) KR20020063286A (es)
CN (1) CN1414963A (es)
AR (1) AR027133A1 (es)
AU (1) AU2352001A (es)
BG (1) BG106846A (es)
BR (1) BR0016954A (es)
CA (1) CA2395984A1 (es)
CZ (1) CZ20022280A3 (es)
EA (1) EA200200733A1 (es)
HU (1) HUP0204084A3 (es)
IL (1) IL149993A0 (es)
IS (1) IS6403A (es)
NO (1) NO20023188D0 (es)
NZ (1) NZ519478A (es)
PL (1) PL355610A1 (es)
SK (1) SK9432002A3 (es)
TR (1) TR200201679T2 (es)
WO (1) WO2001049683A1 (es)
ZA (1) ZA200204464B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
AR055203A1 (es) * 2005-08-31 2007-08-08 Otsuka Pharma Co Ltd Derivados de benzotiofeno con propiedades antipsicoticas
EP2069359B1 (en) 2006-08-21 2014-11-12 Genentech, Inc. Aza-benzothiophenyl compounds and methods of use
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
AR022303A1 (es) * 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion

Also Published As

Publication number Publication date
AU2352001A (en) 2001-07-16
NO20023188L (no) 2002-07-01
ZA200204464B (en) 2003-09-04
TR200201679T2 (tr) 2002-10-21
JP2003519229A (ja) 2003-06-17
IL149993A0 (en) 2002-12-01
EA200200733A1 (ru) 2002-12-26
CN1414963A (zh) 2003-04-30
CZ20022280A3 (cs) 2002-10-16
HUP0204084A3 (en) 2005-02-28
KR20020063286A (ko) 2002-08-01
IS6403A (is) 2002-05-31
BR0016954A (pt) 2003-04-29
HUP0204084A2 (hu) 2003-03-28
SK9432002A3 (en) 2002-11-06
BG106846A (en) 2003-02-28
WO2001049683A1 (en) 2001-07-12
NZ519478A (en) 2004-02-27
NO20023188D0 (no) 2002-07-01
US20030050306A1 (en) 2003-03-13
CA2395984A1 (en) 2001-07-12
PL355610A1 (en) 2004-05-04
EP1246820A1 (en) 2002-10-09

Similar Documents

Publication Publication Date Title
AR066460A2 (es) Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos
ECSP045229A (es) Piridinonas sustituidas como moduladores de la p38 map quinasa
AR072906A1 (es) Nucleosidos modificados utiles como antivirales
CO6321153A2 (es) Derivados de cromeno y cromano y sus usos
PE20021010A1 (es) Derivados espirociclicos como inhibidores de fosfodiesterasa-7
AR054799A1 (es) Derivados de oxindol
ECSP045003A (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos.
AR029301A1 (es) Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
CR9459A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
AR032679A1 (es) Derivados del acido isoftalico como inhibidores de metaloproteinasas de la matriz
UY26143A1 (es) Derivados heterocíclicos útiles como agentes anticancerosos
ES2119124T3 (es) Bencimidazoles utiles para el tratamiento de trastornos del sistema nervioso.
PA8575401A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso
UY28150A1 (es) Agentes terapeuticos
MX9605128A (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
UY27976A1 (es) Piperazinas heterocíclicas sustituídas para el tratamiento de la esquizofrenia
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
AR031597A1 (es) Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3
AR022303A1 (es) Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
AR055878A1 (es) Derivados de ciclopropanocarboxamida
AR065863A1 (es) Derivados de imidazolidinona
HN1998000034A (es) Quinoxalinadionas
AR043959A1 (es) Derivados de indolona-acetamida, procesos para prepararlos, composiciones farmaceuticas que los contienen y su uso como productos farmaceuticos
AR082498A1 (es) Derivados ciclicos de carboxamida y urea sustituidos como ligandos del receptor de vainiloide
AR045999A1 (es) Compuesto de eter de piperidina, su uso para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para prepararlo

Legal Events

Date Code Title Description
FA Abandonment or withdrawal